CORESTATE CAPITAL HOLDING S.A. financials
CORESTATE CAPITAL HOLDING S.A.
529900GNB86RB7HRX793 | Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Other income | €15.5M | €10.6M |
| Operating profit (EBIT) | -€187.9M | -€34.4M |
| Finance costs | €25.6M | €29.0M |
| Profit before tax | -€206.2M | -€58.1M |
| Income tax expense | -€13.4M | €6.9M |
| Profit for the year | -€200.1M | -€68.9M |
| — attributable to owners | -€201.1M | -€69.1M |
| — attributable to NCI | €1.0M | €200.0K |
| Total comprehensive income | -€194.7M | -€69.8M |
| Cash flow statement | ||
| Net cash from operating activities | €31.0M | -€63.4M |
| Net cash from investing activities | €9.8M | -€30.1M |
| Purchase of PP&E (capex) | €400.0K | €1.5M |
| Purchase of intangibles | €500.0K | €2.3M |
| Net cash from financing activities | -€56.2M | €79.4M |
| Proceeds from borrowings | €800.0K | €28.5M |
| Repayments of borrowings | €39.5M | €3.1M |
| Lease liability payments | €5.1M | €3.5M |
| Balance sheet | ||
| Total assets | €1.41B | €1.47B |
| Non-current assets | €990.9M | €1.06B |
| Property, plant & equipment | €13.4M | €22.3M |
| Intangible assets & goodwill | €487.2M | €577.7M |
| Current assets | €399.2M | €408.5M |
| Inventories | €100.0M | €73.8M |
| Trade & other receivables | €47.2M | €33.0M |
| Cash & equivalents | €62.8M | €68.2M |
| Total equity | €626.2M | €688.5M |
| — attributable to owners | €623.2M | €685.8M |
| Non-controlling interests | €3.0M | €2.7M |
| Non-current liabilities | €349.1M | €548.8M |
| Deferred tax liabilities | €17.5M | €13.0M |
| Derived metrics | ||
| Free cash flow | €30.6M | -€64.9M |
| Return on equity | -32.0% | -10.0% |
| Cash conversion ratio | -0.15× | 0.92× |
| Capex coverage | 77.50× | -42.27× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade and Other Receivables | €21.4M | -€74.4M |
| Adjustments For Increase Decrease In Trade and Other Payables | €18.4M | €13.5M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €2.4M | €1.0M |
| Adjustments For Provisions | €3.6M | -€2.8M |
| Adjustments For Sharebased Payments | €3.5M | €1.2M |
| Adjustments For Undistributed Profits of Associates | -€200.0K | -€9.3M |
| Basic and Diluted Earnings Loss Per Share From Continuing Operations | €-6.29 | €-2.87 |
| Basic and Diluted Earnings Loss Per Share From Discontinued Operations | €-0.23 | €-0.17 |
| Brokerage Fee Income | €9.7M | €15.1M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €75.7M | €91.2M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€7.5M | €24.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.0M | €200.0K |
| Comprehensive Income Attributable To Owners of Parent | -€195.7M | -€70.0M |
| Current Bonds Issued and Current Portion of Noncurrent Bonds Issued | €190.9M | — |
| Current Contract Assets | €58.5M | €51.0M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €429.4M | €227.7M |
| Current Receivables Due From Associates | €16.8M | €13.6M |
| Current Restricted Cash and Cash Equivalents | €12.9M | €23.0M |
| Current Tax Assets Current | €2.5M | €2.7M |
| Current Tax Liabilities Current | €29.5M | €36.0M |
| Deferred Tax Assets | €41.5M | €20.7M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €214.3M | €50.6M |
| Equity and Liabilities | €1.41B | €1.47B |
| Finance Income | €7.3M | €5.2M |
| Gains Losses On Exchange Differences On Translation Net of Tax | €4.4M | -€1.7M |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -€2.9M | -€6.8M |
| Gains Losses Recognised When Control In Subsidiary Is Lost | -€2.7M | -€800.0K |
| General and Administrative Expense | €59.5M | €45.4M |
| Income Taxes Paid Refund Classified As Operating Activities | €26.3M | €15.1M |
| Increase Decrease In Cash and Cash Equivalents | -€15.5M | -€14.2M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €0 | — |
| Increase Decrease Through Sharebased Payment Transactions | €3.5M | €1.2M |
| Increase Decrease Through Transfers and Other Changes Equity | -€700.0K | -€3.5M |
| Intangible Assets Other Than Goodwill | €84.8M | €87.8M |
| Interest Paid Classified As Financing Activities | €14.6M | €23.8M |
| Investment Accounted For Using Equity Method | €145.9M | €120.8M |
| Issue of Equity | €129.6M | €78.6M |
| Issued Capital | €2.6M | €1.9M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €8.9M | — |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €23.5M | — |
| Noncurrent Portion of Noncurrent Bonds Issued | €298.0M | €491.0M |
| Noncurrent Portion of Other Noncurrent Borrowings | €3.5M | €4.6M |
| Noncurrent Receivables Due From Associates | €14.9M | €19.6M |
| Noncurrent Trade Receivables | €51.7M | €53.7M |
| Other Comprehensive Income | €5.4M | -€900.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €4.4M | -€1.1M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €1.1M | €200.0K |
| Other Current Assets | €12.1M | €16.6M |
| Other Current Borrowings and Current Portion of Other Noncurrent Borrowings | €68.3M | €68.7M |
| Other Current Financial Assets | €86.5M | €126.7M |
| Other Current Financial Liabilities | €41.4M | €42.0M |
| Other Current Nonfinancial Liabilities | €40.0M | €48.5M |
| Other Expense By Function | €7.5M | €22.9M |
| Other Individually Immaterial Components of Other Comprehensive Income Net of Tax | — | €600.0K |
| Other Longterm Provisions | €1.2M | €1.8M |
| Other Noncurrent Financial Assets | €151.5M | €153.9M |
| Other Noncurrent Financial Liabilities | €19.9M | €29.3M |
| Other Noncurrent Nonfinancial Liabilities | €8.9M | €9.2M |
| Other Reserves | €821.7M | €752.9M |
| Other Shortterm Provisions | €13.6M | €10.1M |
| Proceeds From Issuing Shares | — | €78.6M |
| Proceeds From Sales of Investments Accounted For Using Equity Method | €200.0K | €11.7M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €1.6M | €300.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €3.2M | €8.4M |
| Profit Loss From Continuing Operations | -€192.8M | -€65.1M |
| Profit Loss From Discontinued Operations | -€7.2M | -€3.8M |
| Purchase of Financial Instruments Classified As Investing Activities | — | €6.3M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €1.7M | €16.4M |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | -€2.5M | — |
| Revenue From Dividends | €12.8M | €8.8M |
| Revenue From Interest | €18.1M | €10.3M |
| Sale Or Issue of Treasury Shares | — | €6.4M |
| Share Issue Related Cost | — | €800.0K |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €2.4M | -€9.3M |
| Trade and Other Current Payables To Related Parties | €18.1M | €9.3M |
| Trade and Other Current Payables To Trade Suppliers | €27.6M | €13.1M |
| Trading Income Expense | €1.0M | — |
Every line item above is a fact tagged in CORESTATE CAPITAL HOLDING S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.